ask="2.75"
ask_size="100"
average_daily_volume="269613"
bid="1.25"
bid_size="400"
book_value="0.88"
change="-0.15"
change_from_200_day_moving_average="-1.60"
change_from_50_day_moving_average="-0.43"
change_from_52_week_high="-5.07"
change_From_52_week_low="0.10"
change_in_percent="-8.57%"
close="1.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-36.93M"
eps_estimate_current_year="-1.35"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-1.04"
ex_dividend_date="N/A"
float_shares="28175000"
high="1.80"
high_52_weeks="6.67"
last_trade_date="3/9/2017"
last_trade_price="1.60"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="1.50"
low_52_weeks="1.50"
market_capitalization="48.98M"
moving_average_200_day="3.20"
moving_average_50_day="2.03"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="6.23"
open="1.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-49.99%"
percent_change_from_50_day_moving_average="-21.27%"
percent_change_from_52_week_high="-76.01%"
percent_change_from_52_week_low="+6.67%"
previous_close="1.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.00"
price_per_sales="136.62"
revenue="392168.00"
shares_outstanding="30615000"
short_ratio="12.29"
stock_exchange="NCM"
symbol="TROV"
volume="669942"
weeks_range_52="1.50 - 6.67"
